ClinicalTrials.gg
Not yet recruitingNCT07207655HPVUpdated Oct 6, 2025

Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV)

An interventional study of HPV Card Game in Human Papilloma Virus (HPV) and Hearing Disability, sponsored by Çankırı Karatekin University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-10-06.

Sponsored by Çankırı Karatekin University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Health education is one approach to influencing individuals, groups, or communities to achieve better health. The literature indicates that increasing awareness of HPV, along with participation in early screening and vaccination programs, can positively influence attitudes and behaviors. Therefore, this research will be conducted to determine the effect of education using the card game method on the knowledge and health beliefs of hearing-impaired individuals regarding Human Papilloma Virus (HPV).

Read the detailed description

Human Papillomavirus (HPV) is a highly prevalent virus worldwide, affecting both men and women. HPV is a common sexually transmitted infection that accounts for over 99% of cervical cancer cases. While HPV may not always cause cancer, screening for risky types is important. Cancer screening programs are the most important step in early cancer detection. Early diagnosis, followed by cancer screening, reduces morbidity and mortality. Access to screening services is a key factor in early cancer detection and screening. Access to information and communication with healthcare professionals are crucial for accessing cancer screening programs. Communication barriers appear to be one of the most significant barriers to early cancer diagnosis, screening, and treatment. People with hearing impairments are a unique group experiencing communication barriers. They face challenges accessing health-related information, communicating with healthcare professionals, obtaining adequate information from healthcare professionals, and understanding the information they receive. People with hearing impairments have lower literacy and health literacy rates than those without hearing impairments. Therefore, hearing-impaired individuals have less knowledge about HPV than hearing-impaired individuals, and their participation in HPV screening is more limited. It is necessary to increase the knowledge and awareness of hearing-impaired individuals about HPV screening. Health education utilizes booklets, digital instant messaging, flashcards, videos, video conferencing, and similar educational methods. One such educational method is playing with cards. Card games are fun and educational. These methods offer the advantages of being simple, playable anywhere, easy to store, suitable for children or adults in large or small groups, and actively engaging participants in the game. Studies in the literature report that providing education and information through the educational environment of the four-card game helps increase participants' knowledge and self-efficacy. Health education is one approach to influencing individuals, groups, or communities to achieve better health. The literature indicates that increasing awareness of HPV, along with participation in early screening and vaccination programs, can positively influence attitudes and behaviors. Therefore, this research will be conducted to determine the effect of education using the card game method on the knowledge and health beliefs of hearing-impaired individuals regarding Human Papilloma Virus (HPV).

02

Conditions studied

  • Human Papilloma Virus (HPV)
  • Hearing Disability

Browse trials for

Keywords

  • HPV
  • Hearing impaired individual
  • health belief
  • health belief, information
03

In context

Papilloma

89 studies on the registry are indexed under Papilloma; 20 are open to participants now.

This study's planned enrollment of 40 is below the median of 118 across 65 interventional studies indexed under Papilloma.

Browse Papilloma studies →

Lead sponsor

Çankırı Karatekin University is the lead sponsor of 66 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participating in the study voluntarily
  • Being hearing impaired
  • Knowing sign language
  • Being a native Turkish speaker
  • Being over 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Having a disability other than hearing loss
  • Not knowing sign language
  • Having a psychiatric illness
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    HPV Card Game Group

    HPV Card Game Group: Twenty individuals in the intervention group will receive HPV education using the card game method.

    Other: HPV Card Game

  • No intervention
    Control Group

    No Intervention: Control Group Arm Description: The researcher will not apply to this group.

Interventions

  • OtherHPV Card Game

    HPV Card Game Group: Twenty individuals in the intervention group will receive HPV education using the card game method.

06

What researchers measure

Primary outcomes

  1. Pre-test

    HPV Knowledge Level The HPV Information Form: The form is a short form containing 7 information statements. For each statement, 1 point is awarded for a correct answer; no points are awarded for incorrect answers or "I don't know." The total knowledge score is calculated by adding the number of correct answers. A higher score indicates a higher level of knowledge.

    Time frame: Before the card game, individuals will be given an HPV Information Form.

  2. Pretest

    HPV Health Belief Level HPV Infection and Vaccination Health Belief Model Scale: Participant responses are scored based on item scores, and the total score for each subsection is calculated. The calculated total score is divided by the number of items in the subsection to calculate the individual's severity, barrier, susceptibility, and benefit scores. The average score for each subsection ranges from 1 to 4. A high benefit perception score indicates that a participant believes the HPV vaccine is beneficial; a high severity perception score indicates that HPV infection is a serious problem; a high barrier perception score indicates that the barriers to vaccination are numerous; and a high susceptibility perception score indicates significant sensitivity to this issue.

    Time frame: Before the card game, the Health Belief Model Scale on HPV Infection and Vaccination will be administered.

Secondary outcomes

  1. Post-test

    HPV Information level The HPV Information Form: The form is a short form containing 7 information statements. For each statement, 1 point is awarded for a correct answer; no points are awarded for incorrect answers or "I don't know." The total knowledge score is calculated by adding the number of correct answers. A higher score indicates a higher level of knowledge.

    Time frame: One month after the card game, the HPV Information Form will be applied to the individuals.

  2. Post-test

    HPV Health Belief Model Scale HPV Infection and Vaccination Health Belief Model Scale: Participant responses are scored based on item scores, and the total score for each subsection is calculated. The calculated total score is divided by the number of items in the subsection to calculate the individual's severity, barrier, susceptibility, and benefit scores. The average score for each subsection ranges from 1 to 4. A high benefit perception score indicates that a participant believes the HPV vaccine is beneficial; a high severity perception score indicates that HPV infection is a serious problem; a high barrier perception score indicates that the barriers to vaccination are numerous; and a high susceptibility perception score indicates significant sensitivity to this issue.

    Time frame: One month after the card game, the Health Belief Model Scale on HPV Infection and Vaccination will be administered.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Oct 2025, 0 months later.

Of 28 interventional studies with no phase under Papilloma, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 38. This study's planned 0 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2025
First posted
Oct 6, 2025
StartEst.
Sep 28, 2025
Primary completionEst.
Oct 15, 2025
CompletionEst.
Dec 31, 2025
Last update
Oct 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07207655
Lead sponsor
Çankırı Karatekin University
Responsible party
Sakine Yılmaz (Assistant Professor Doctor, Çankırı Karatekin University) — Principal investigator
First posted
Oct 6, 2025
Start date
Sep 28, 2025 (estimated)
Primary completion
Oct 15, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Oct 6, 2025

Study contacts

Sakine Yılmaz
Contact
sakinee_yilmaz@hotmail.com
+905439380626
Bilgesu Çelik, Research assistant
Contact
bilgesucelik@karatekin.edu.tr
+905078506039
Sakine Yılmaz, Assistant Professor Doctor
principal investigator · Çankırı Karatekin University
Bilgesu Çelik, Research assistant
study chair · Çankırı Karatekin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion